Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Pharnext

    MCap

    EUR1m

    Last close

    EUR0.10

    ▲ 0.06 (150.00%)

    Silver Spruce Resources

    MCap

    CAD3m

    Last close

    CAD0.02

    ▲ 0.01 (100.00%)

    Actinogen Medical

    MCap

    AUD48m

    Last close

    AUD0.03

    ▲ 0.01 (50.00%)

  • Sectors

    Sectors

  • Investment Strategy

    Investment Strategy

    View All

    Latest

  • Thematics

    Thematics

    View All Thematics

    Latest

Transgene (EU: TNG)

Currency in -

Last close As at 22/09/2023

-2.49

— 0.00 (0.00%)

Market capitalisation

209m

Edison Investment Research is terminating coverage on Transgene. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Latest Insights

View More

Healthcare | Update

Transgene — TG4001 first efficacy data presented at ESMO

Healthcare | Outlook

Transgene — PHOCUS turns to earlier-stage assets

Healthcare | Update

Transgene — Defining data from lead assets by year-end

Healthcare | Update

Transgene — TG4010 and Pexa-Vec readouts to define 2019
Visit Website

Sector

Healthcare

Financials

Edison Investment Research is terminating coverage on Transgene. Please note you should no longer rely on any previous research or estimates for these companies. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.